fenofibrate has been researched along with Cancer of Prostate in 6 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of severe rhabdomyolysis resulting in acute renal failure caused by an interaction between ketoconazole and simvastatin in a patient with prostate cancer." | 7.77 | Rhabdomyolysis in a Prostate Cancer Patient Taking Ketoconazole and Simvastatin: Case Report and Review of the Literature. ( Atkinson, BJ; Pagliaro, LC; Watkins, JL, 2011) |
| "To report a case of severe rhabdomyolysis resulting in acute renal failure caused by an interaction between ketoconazole and simvastatin in a patient with prostate cancer." | 3.77 | Rhabdomyolysis in a Prostate Cancer Patient Taking Ketoconazole and Simvastatin: Case Report and Review of the Literature. ( Atkinson, BJ; Pagliaro, LC; Watkins, JL, 2011) |
| "Fenofibrate is a fibric acid derivative which exhibits a role of peroxisome proliferator-activated receptor-alpha agonist." | 1.48 | Fenofibrate inhibits the growth of prostate cancer through regulating autophagy and endoplasmic reticulum stress. ( Shen, Q; Shen, Z; Tao, T; Xiao, J; Xuan, Q; Zhao, F, 2018) |
| "Thus, fenofibrate affects prostate cancer cell invasion via an orchestrated action on versatile cancer cell properties determining this process." | 1.37 | Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations. ( Bonarek, P; Czyż, J; Drukała, J; Górecki, A; Madeja, Z; Majka, M; Miękus, K; Reiss, K; Szpak, K; Wybieralska, E, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lian, X | 1 |
| Gu, J | 1 |
| Gao, B | 1 |
| Li, Y | 1 |
| Damodaran, C | 1 |
| Wei, W | 1 |
| Fu, Y | 1 |
| Cai, L | 1 |
| Tao, T | 2 |
| Zhao, F | 1 |
| Xuan, Q | 1 |
| Shen, Z | 1 |
| Xiao, J | 1 |
| Shen, Q | 1 |
| Piwowarczyk, K | 1 |
| Wybieralska, E | 2 |
| Baran, J | 1 |
| Borowczyk, J | 1 |
| Rybak, P | 1 |
| Kosińska, M | 1 |
| Włodarczyk, AJ | 1 |
| Michalik, M | 1 |
| Siedlar, M | 1 |
| Madeja, Z | 2 |
| Dobrucki, J | 1 |
| Reiss, K | 2 |
| Czyż, J | 2 |
| Watkins, JL | 1 |
| Atkinson, BJ | 1 |
| Pagliaro, LC | 1 |
| Szpak, K | 1 |
| Górecki, A | 1 |
| Bonarek, P | 1 |
| Miękus, K | 1 |
| Drukała, J | 1 |
| Majka, M | 1 |
| Zhao, H | 1 |
| Zhu, C | 1 |
| Qin, C | 1 |
| Li, J | 1 |
| Cheng, G | 1 |
| Li, P | 1 |
| Cao, Q | 1 |
| Meng, X | 1 |
| Ju, X | 1 |
| Shao, P | 1 |
| Hua, L | 1 |
| Gu, M | 1 |
| Yin, C | 1 |
6 other studies available for fenofibrate and Cancer of Prostate
| Article | Year |
|---|---|
Fenofibrate inhibits mTOR-p70S6K signaling and simultaneously induces cell death in human prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulatio | 2018 |
Fenofibrate inhibits the growth of prostate cancer through regulating autophagy and endoplasmic reticulum stress.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Proliferat | 2018 |
Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells.
Topics: Cell Adhesion; Cell Communication; Cell Line, Tumor; Cell Movement; Coculture Techniques; Endothelia | 2015 |
Rhabdomyolysis in a Prostate Cancer Patient Taking Ketoconazole and Simvastatin: Case Report and Review of the Literature.
Topics: Acute Kidney Injury; Aged; Antineoplastic Agents; Drug Interactions; Drug Therapy, Combination; Feno | 2011 |
Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations.
Topics: Cell Communication; Cell Line, Tumor; Cell Movement; Cell Survival; Connexin 43; Fenofibrate; Gap Ju | 2011 |
Fenofibrate down-regulates the expressions of androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP.
Topics: Androgen Receptor Antagonists; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Down- | 2013 |